SIM0237 / Simcere 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SIM0237 / Simcere
NCT06186414: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination With BCG in NMIBC

Recruiting
1
108
RoW
SIM0237, SIM0237 and BCG
Jiangsu Simcere Pharmaceutical Co., Ltd., Shanghai Xianxiang Medical Technology Co., Ltd.
Non-Muscle-Invasive Bladder Cancer (NMIBC)
01/27
12/30
NCT05781360: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors

Recruiting
1
192
US, RoW
SIM0237
Jiangsu Simcere Pharmaceutical Co., Ltd., Shanghai Xianxiang Medical Technology Co., Ltd., Simcere Zaiming
Locally Advanced Unresectable or Metastatic Solid Tumor
04/25
01/26

Download Options